Essential roles of epithelial bone morphogenetic protein signaling during prostatic development

Endocrinology

Volumn 155, Issue 7, 2014, Pages 2534-2544

  Omori, Akiko ^a   Miyagawa, Shinichi ^b   Ogino, Yukiko ^b   Harada, Masayo ^c   Ishii, Kenichiro ^d   Sugimura, Yoshiki ^d   Ogino, Hajime ^e   Nakagata, Naomi ^f   Yamada, Gen ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b OKAZAKI INSTITUTE FOR INTEGRATIVE BIOSCIENCE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NAGAHAMA INSTITUTE OF BIO SCIENCE AND TECHNOLOGY   (Japan)

^f KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; PROBASIN; PROSTATIC SECRETORY PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX3.1; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN RETRIEVAL; ARTICLE; BASEMENT MEMBRANE; CELL MATURATION; CELL PROLIFERATION; DNA RECOMBINATION; ENHANCER REGION; EPITHELIUM BASAL CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROSTATE DEVELOPMENT; PROSTATE EPITHELIUM; PROSTATE SECRETION; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATOR GENE; SIGNAL TRANSDUCTION; TESTOSTERONE BLOOD LEVEL; TISSUE DIFFERENTIATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEODOMAIN PROTEINS; HUMANS; HYPERPLASIA; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTATION; PHOSPHORYLATION; PROSTATE; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSCRIPTION FACTORS;

EID: 84903287130     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-2054     Document Type: Article

References (68)

1. Marker PC, Donjacour AA, Dahiya R, Cunha GR. Hormonal, cellular, and molecular control of prostatic development. Dev Biol. 2003;253(2):165-174. (Pubitemid 36259879)
2. Kypta RM, Waxman J. Wnt/β-catenin signalling in prostate cancer. Nat Rev Urol. 2012;9:418-428.
3. Sugimura Y, Cunha GR, Donjacour AA. Morphogenesis of ductal networks in the mouse prostate. Biol Reprod. 1986;34(5):961-971.
4. Thomson AA, Marker PC. Branching morphogenesis in the prostate gland and seminal vesicles. Differentiation. 2006;74(7):382-392. (Pubitemid 44215409)
5. Prins GS, Putz O. Molecular signaling pathways that regulate prostate gland development. Differentiation. 2008;76(6):641-659. (Pubitemid 352032742)
6. Donjacour AA, Cunha GR. The effect of androgen deprivation on branching morphogenesis in the mouse prostate. Dev Biol. 1988;128(1):1-14.
7. Romero D, Kawano Y, Bengoa N, et al. Downregulation of Dickkopf-3 disrupts prostate acinar morphogenesis through TGF-β/Smad signalling. J Cell Sci. 2013;126(Pt 8):1858-1867.
8. Zhang Y, Zhang J, Lin Y, et al. Role of epithelial cell fibroblast growth factor receptor substrate 2α in prostate development, regeneration and tumorigenesis. Development. 2008;135(4):775-784. (Pubitemid 351405030)
9. Freestone SH, Marker P, Grace OC, et al. Sonic hedgehog regulates prostatic growth and epithelial differentiation. Dev Biol. 2003;264(2):352-362. (Pubitemid 37490974)
10. Kruithof-de Julio M, Shibata M, Desai N, et al. Canonical Wnt signaling regulates Nkx3.1 expression and luminal epithelial differentiation during prostate organogenesis. Dev Dyn. 2013;242(10):1160-1171.
11. Huang L, Pu Y, Hu WY, et al. The role of Wnt5a in prostate gland development. Dev Biol. 2009;328(2):188-199.
12. Bhowmick NA, Chytil A, Plieth D, et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science. 2004;303(5659):848-851. (Pubitemid 38174665)
13. Komatsu Y, Mishina Y. Establishment of left-right asymmetry in vertebrate development: the node in mouse embryos. Cell Mol Life Sci. 2013;70(24):4659- 4666.
14. Massagué J, Xi Q. TGF-β control of stem cell differentiation genes. FEBS Lett. 2012;586(14):1953-1958.
15. Miyazaki H, Watabe T, Kitamura T, Miyazono K. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells. Oncogene. 2004;23(58):9326-9335. (Pubitemid 40069665)
16. Grishina IB, Kim SY, Ferrara C, Makarenkova HP, Walden PD. BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling. Dev Biol. 2005;288(2):334-347. (Pubitemid 41790747)
17. Cook C, Vezina CM, Allgeier SH, et al. Noggin is required for normal lobe patterning and ductal budding in the mouse prostate. Dev Biol. 2007;312(1):217-230. (Pubitemid 350182443)
18. Lamm ML, Podlasek CA, Barnett DH, et al. Mesenchymal factor bone morphogenetic protein 4 restricts ductal budding and branching morphogenesis in the developing prostate. Dev Biol. 2001;232(2):301-314. (Pubitemid 32337095)
19. Omori A, Harada M, Ohta S, et al. Epithelial Bmp (bone morphogenetic protein) signaling for bulbourethral gland development: a mouse model for congenital cystic dilation. Congenit Anom (Kyoto). 2011;51(3):102-109.
20. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR. Requirement of Bmpr1a for Müllerian duct regression during male sexual development. Nat Genet. 2002;32(3):408-410. (Pubitemid 35266116)
21. Wang Y, Hayward S, Cao M, Thayer K, Cunha G. Cell differentiation lineage in the prostate. Differentiation. 2001;68(4-5):270-279. (Pubitemid 33754999)
22. Hudson DL, Guy AT, Fry P, O'Hare MJ, Watt FM, Masters JR. Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J Histochem Cytochem. 2001;49(2):271-278. (Pubitemid 32113389)
23. Ousset M, Van Keymeulen A, Bouvencourt G, et al. Multipotent and unipotent progenitors contribute to prostate postnatal development. Nat Cell Biol. 2012;14(11):1131-1138.
24. Signoretti S, Loda M. Prostate stem cells: from development to cancer. Semin Cancer Biol. 2007;17(3):219-224. (Pubitemid 46413076)
25. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, Witte ON. Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci USA. 2010;107(6):2610-2615.
26. Wang X, Kruithof-de Julio M, Economides KD, et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature. 2009;461(7263):495-500.
27. Li X, Placencio V, Iturregui JM, et al. Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis. Oncogene. 2008;27(56):7118-7130.
28. Matusik RJ, Jin RJ, Sun Q, et al. Prostate epithelial cell fate. Differentiation. 2008;76(6):682-698. (Pubitemid 352036646)
29. Wang XD, Leow CC, Zha J, et al. Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Dev Biol. 2006;290(1):66-80. (Pubitemid 43083604)
30. Gao N, Ishii K, Mirosevich J, et al. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development. 2005;132(15):3431-3443. (Pubitemid 41246118)
31. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, et al. Roles for Nkx3.1 in prostate development and cancer. Genes Dev. 1999;13(8):966-977. (Pubitemid 29200980)
32. Abdulkadir SA, Magee JA, Peters TJ, et al. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol Cell Biol. 2002;22(5):1495-1503. (Pubitemid 34150785)
33. Sciavolino PJ, Abrams EW, Yang L, Austenberg LP, Shen MM, Abate-Shen C. Tissue-specific expression of murine Nkx3.1 in the male urogenital system. Dev Dyn. 1997;209(1):127-138. (Pubitemid 27188345)
34. Tanaka M, Komuro I, Inagaki H, Jenkins NA, Copeland NG, Izumo S. Nkx3.1, a murine homolog of Drosophila bagpipe, regulates epithelial ductal branching and proliferation of the prostate and palatine glands. Dev Dyn. 2000;219(2):248-260.
35. Tan PY, Chang CW, Chng KR, Wansa KD, Sung WK, Cheung E. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. Mol Cell Biol. 2012;32(2):399-414.
36. Thomas MA, Preece DM, Bentel JM. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3′ untranslated region. Biochem J. 2010;425(3):575-583.
37. Harfe BD, Scherz PJ, Nissim S, Tian H, McMahon AP, Tabin CJ. Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities. Cell. 2004;118(4):517-528. (Pubitemid 39485670)
38. Mishina Y, Hanks MC, Miura S, Tallquist MD, Behringer RR. Generation of Bmpr/Alk3 conditional knockout mice. Genesis. 2002;32(2):69-72. (Pubitemid 34211699)
39. Srinivas S, Watanabe T, Lin CS, et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol. 2001;1:4.
40. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet. 1999;21(1):70-71. (Pubitemid 29036285)
41. Feil R, Wagner J, Metzger D, Chambon P. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem Biophys Res Commun. 1997;237(3):752-757. (Pubitemid 27434760)
42. Boyle S, Misfeldt A, Chandler KJ, et al. Fate mapping using Cited1-CreERT2 mice demonstrates that the cap mesenchyme contains self-renewing progenitor cells and gives rise exclusively to nephronic epithelia. Dev Biol. 2008;313(1):234-245. (Pubitemid 350298313)
43. Kim MJ, Cardiff RD, Desai N, et al. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA. 2002;99(5):2884-2889. (Pubitemid 34240555)
44. Fujimoto N, Akimoto Y, Suzuki T, Kitamura S, Ohta S. Identification of prostatic-secreted proteins in mice by mass spectrometric analysis and evaluation of lobe-specific and androgen-dependent mRNA expression. J Endocrinol. 2006;190(3):793-803. (Pubitemid 44560254)
45. Miyagawa S, Matsumaru D, Murashima A, et al. The role of sonic hedgehog-Gli2 pathway in the masculinization of external genitalia. Endocrinology. 2011;152(7):2894-2903.
46. Chen H, Mutton LN, Prins GS, Bieberich CJ. Distinct regulatory elements mediate the dynamic expression pattern of Nkx3.1. Dev Dyn. 2005;234(4):961-973. (Pubitemid 41741167)
47. Ogino H, Ochi H, Uchiyama C, Louie S, Grainger RM. Comparative genomics-based identification and analysis of cis-regulatory elements. Methods Mol Biol. 2012;917:245-263.
48. Renfree MB, Harry JL, Shaw G. The marsupial male: a role model for sexual development. Philos Trans R Soc Lond B Biol Sci. 1995;350(1333):243-251.
49. Behringer RR, Eakin GS, Renfree MB. Mammalian diversity: gametes, embryos and reproduction. Reprod Fertil Dev. 2006;18(1-2):99-107. (Pubitemid 41831080)
50. He XC, Zhang J, Tong WG, et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat Genet. 2004;36(10):1117-1121. (Pubitemid 41184475)
51. Kobielak K, Pasolli HA, Alonso L, Polak L, Fuchs E. Defining BMP functions in the hair follicle by conditional ablation of BMP receptor IA. J Cell Biol. 2003;163(3):609-623. (Pubitemid 37429873)
52. Haramis AP, Begthel H, van den Born M, et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science. 2004;303(5664):1684-1686. (Pubitemid 38338329)
53. Shappell SB, Thomas GV, Roberts RL, et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res. 2004;64(6):2270-2305. (Pubitemid 38339483)
54. Wang Y, Sudilovsky D, Zhang B, et al. A human prostatic epithelial model of hormonal carcinogenesis. Cancer Res. 2001;61(16):6064-6072. (Pubitemid 32762541)
55. Sun J, Chen H, Chen C, et al. Prenatal lung epithelial cell-specific abrogation of Alk3-bone morphogenetic protein signaling causes neonatal respiratory distress by disrupting distal airway formation. Am J Pathol. 2008;172(3):571-582. (Pubitemid 351354531)
56. Auclair BA, Benoit YD, Rivard N, Mishina Y, Perreault N. Bone morphogenetic protein signaling is essential for terminal differentiation of the intestinal secretory cell lineage. Gastroenterology. 2007;133(3):887-896. (Pubitemid 47374143)
57. Ming Kwan K, Li AG, Wang XJ, Wurst W, Behringer RR. Essential roles of BMPR-IA signaling in differentiation and growth of hair follicles and in skin tumorigenesis. Genesis. 2004;39(1):10-25. (Pubitemid 38738012)
58. Song H, Zhang B, Watson MA, Humphrey PA, Lim H, Milbrandt J. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis. Oncogene. 2009;28(37):3307-3319.
59. Simons BW, Hurley PJ, Huang Z, et al. Wnt signaling though β-catenin is required for prostate lineage specification. Dev Biol. 2012;371(2):246-255.
60. Waite KA, Eng C. BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. Hum Mol Genet. 2003;12(6):679-684. (Pubitemid 36372494)
61. Ding Z, Wu CJ, Chu GC, et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature. 2011;470(7333):269-273.
62. Banach-Petrosky W, Jessen WJ, Ouyang X, et al. Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice. Cancer Res. 2007;67(19):9089-9096. (Pubitemid 47535894)
63. Atala A. Re: Nkx3.1 and myc crossregulate shared target genes in mouse and human prostate tumorigenesis. J Urol. 2013;189(2):772.
64. Francis JC, Thomsen MK, Taketo MM, Swain A. β-Catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma. PLoS Genet. 2013;9(1):e1003180.
65. Kypta R, Unda M, Carracedo A. Is the bench getting closer to the bedside in the war on cancer? A quick look at prostate cancer. Front Endocrinol (Lausanne). 2012;3:53.
66. Lang SH, Frame FM, Collins AT. Prostate cancer stem cells. J Pathol. 2009;217(2):299-306.
67. van Leenders GJ, Gage WR, Hicks JL, et al. Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol. 2003;162(5):1529-1537. (Pubitemid 36512835)
68. Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM, Schalken JA. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res. 1992;52(22):6182-6187.